Type 2 diabetes (T2D) has become a burden for society, and the incidence of the disease continues to increase. A range of therapies is available to control glycaemia in T2D patients; however, these drugs have undesired side-effects and there is a need to develop improved treatments. ...
1. New treatments for type 2 diabetes: Cardiovascular protection beyond glucose lowering? [J] . JayawardeneD., WardG.M., ONealD.N., Heart, lung & circulation . 2014,第11期 机译:2型糖尿病的新疗法:除了降低血糖外,还能提供心血管保护吗? 2. The joint effects of different types of glucose...
Barnett AH. New treatments in type 2 diabetes: a focus on the incretin- based therapies. Clin Endocrinol. 2009;70(3):343-353.Barnett AH. New treatments in Type 2 diabetes: a focus on the incretin-based therapies. Clin. Endocrinol. 70(3), 343-353 (2009)....
New treatments for type 2 diabetes Type 2 diabetes (T2D) has become a burden for society, and the incidence of the disease continues to increase. A range of therapies is available to control glycaemia in T2D patients; however, these drugs have undesired side-effects and t... Cascales,Laura...
New treatments for type 2 diabetes mellitus:combined therapy with sitagliptin. Gagliardino,J.J. et al. Expert Opinion on Pharmacotherapy . 2008New treatments for type 2 diabetes mellitus:combined therapy with sitagliptin. Gagliardino,J.J... JJ Gagliardino,S Santoro,S Arellano,... - 《Expert ...
Saxagliptin is a novel dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor) for the treatment of type 2 diabetes, with a duration profile for once daily dosing. It is highly selective for DPP-4 in comparison to other enzymes of the dipeptidyl peptidase family. DPP-4 inhibitors elevate plasma con...
The finding could lead to more effective treatments for type 2 diabetes, says study leader Brian N. Finck, associate professor of medicine. One drug that the researchers experimented with in their study may have such an effect – the investigational drug MSDC-0602. According to the manufacturer,...
Thus, new agents with novel actions are required to complement and extend the capabilities of existing treatments. Insulin resistance and beta-cell failure, which are crucial components in the pathogenesis of Type 2 diabetes, remain the underlying targets for new drugs. Recently introduced agents ...
Insulin is a hormone that helps the body turn sugar in the blood into energy for the body. In people with type 2 diabetes, the body either does not make enough insulin or does not use insulin properly, which leads to rising levels of blood sugar. Eventually, high blood sugar can increase...
(HealthDay) -- A new type of medication for type 2 diabetes helps to lower blood sugar levels when used in concert with insulin and other diabetes drugs, new research suggests.